References
- Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6:95.
- Cheng L, Chen J, Fu Q, et al. Chinese society of allergy guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2018;10:300–353.
- Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol. 2016;16(5):279–294.
- Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145:1082–1123.
- Sampath V, Sindher SB, Alvarez Pinzon AM, et al. Can food allergy be cured? What are the future prospects? Allergy. 2020;75:1316–1326.
- Senti G, Johansen P, Kündig TM. Intralymphatic immunotherapy. Curr Opin Allergy Clin Immunol. 2009;9:537–543.
- Weidner J, Bartel S, Kılıç A, et al. Spotlight on microRNAs in allergy and asthma. Allergy. 2021;76:1661–1678.
- Zhang XH, Zhang YN, Li HB, et al. Overexpression of miR-125b, a novel regulator of innate immunity, in eosinophilic chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med. 2012;185:140–151.
- Lu TX, Hartner J, Lim EJ, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol. 2011;187:3362–3373.
- Chen XF, Zhang LJ, Zhang J, et al. MiR-151a is involved in the pathogenesis of atopic dermatitis by regulating interleukin-12 receptor β2. Exp Dermatol. 2018;27:427–432.
- Wang T, Cai W, Wu Q, et al. Exosomal lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1)contributes to the progression of allergic rhinitis via modulating microRNA-511/Nuclear receptor subfamily 4 group A member 2 (NR4A2) axis. Bioengineered. 2021;12:8067–8079.
- Zhang S, Lin S, Tang Q, et al. Knockdown of miR‑205‑5p alleviates the inflammatory response in allergic rhinitis by targeting B‑cell lymphoma 6. Mol Med Rep. 2021;24. DOI:10.3892/mmr.2021.12458
- Lin W, Su F, Gautam R, et al. Raf kinase inhibitor protein negatively regulates FcεRI-mediated mast cell activation and allergic response. Proc Natl Acad Sci U S A. 2018;115:E9859–e9868.
- Wenzel SE, Tyurina YY, Zhao J, et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell. 2017;171:628–641.e626.
- Zhao J, Dar HH, Deng Y, et al. PEBP1 acts as a rheostat between prosurvival autophagy and ferroptotic death in asthmatic epithelial cells. Proc Natl Acad Sci U S A. 2020;117:14376–14385.
- Kim W, Cho SB, Jung HY, et al. Phosphatidylethanolamine-Binding protein 1 ameliorates ischemia-induced inflammation and neuronal damage in the rabbit spinal cord. Cells. 2019;8. DOI:10.3390/cells8111370.
- Min HJ, Park JS, Kim KS, et al. Th2 cytokines-DUOX2-ROS-HMGB1 translocation axis is important in the pathogenesis of allergic rhinitis. Clin Sci (Lond). 2021;135:483–494.
- Low SS, Ji D, Chai WS, et al. Recent progress in nanomaterials modified electrochemical biosensors for the detection of microRNA. Micromachines (Basel). 2021;12. 10.3390/mi12111409.
- Low SS, Pan Y, Ji D, et al., Smartphone-based portable electrochemical biosensing system for detection of circulating microRNA-21 in saliva as a proof-of-Concept. 2020; Sensors and Actuators B Chemical. 308:127718.
- Kim WG, Kang GD, Kim HI, et al. Bifidobacterium longum IM55 and Lactobacillus plantarum IM76 alleviate allergic rhinitis in mice by restoring Th2/Treg imbalance and gut microbiota disturbance. Benef Microbes. 2019;10:55–67.
- Wang W, Zhou Q, Liu L, et al. Anti-allergic activity of emodin on IgE-mediated activation in RBL-2H3 cells. Pharmacol Rep. 2012;64:1216–1222.
- Yang JJ, Zhao YH, Yin KW, et al. Dexmedetomidine inhibits inflammatory response and oxidative stress through regulating miR-205-5p by targeting HMGB1 in cerebral ischemic/reperfusion. Immunopharmacol Immunotoxicol. 2021;43(4):1–9.
- Yu X, Chen X, Sun T. MicroRNA-205-5p Targets HMGB1 to suppress inflammatory responses during lung injury after hip fracture. Biomed Res Int. 2019;7304895. DOI:10.1155/2019/7304895
- Shimizu S, Kouzaki H, Kato T, et al. HMGB1-TLR4 signaling contributes to the secretion of interleukin 6 and interleukin 8 by nasal epithelial cells. Am J Rhinol Allergy. 2016;30:167–172.
- Tang H, Li T, Han X, et al. TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model. Int Immunopharmacol. 2019;73:254–260.
- Yuan Y, Liu Q, Zhao J, et al. SIRT1 attenuates murine allergic rhinitis by downregulated HMGB 1/TLR4 pathway. Scand J Immunol. 2018;87:e12667.
- Wu G, Yang G, Zhang R, et al. Altered microRNA expression profiles of extracellular vesicles in nasal mucus from patients with allergic rhinitis. Allergy Asthma Immunol Res. 2015;7:449–457.
- Rebane A, Akdis CA. MicroRNAs in allergy and asthma. Curr Allergy Asthma Rep. 2014;14:424.
- Specjalski K, Jassem E. MicroRNAs: potential biomarkers and targets of therapy in allergic diseases? Arch Immunol Ther Exp (Warsz). 2019;67:213–223.
- Farooqi AA, Li Y, Sarkar FH. The biological complexity of RKIP signaling in human cancers. Exp Mol Med. 2015;47:e185.
- Li Y, Tian Z, Tan Y, et al. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer. Mol Cancer. 2020;19:109.
- Liu H, Li P, Li B, et al. RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224. Tumour Biol. 2014;35(10):10095–10103.
- Shvartsur A, Givechian KB, Garban H, et al. Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma. J Exp Clin Cancer Res. 2017;36:62.
- Wang Y, Bonavida B. A new linkage between the tumor suppressor RKIP and autophagy: targeted therapeutics. Crit Rev Oncog. 2018;23:281–305.
- Zhu CX, Li WZ, Guo YL, et al. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment. Neoplasma. 2018;65:228–233.